Seeking Alpha

More on Rite Aid's (RAD) FQ1: Same-store sales 2.5% higher Y/Y, with pharmacy sales up 2.4%...

More on Rite Aid's (RAD) FQ1: Same-store sales 2.5% higher Y/Y, with pharmacy sales up 2.4% impacted by Walgreen/Express Scripts dispute. SG&A expenses as a percentage of revenue rose to 26.1%, from 24.8% a year ago. Expects sales of $25.3B-$25.7B in FY13 and EPS to fall in a range of -$0.13 to -$0.29. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|